Jack A. Khattar sold $2.6M of Supernus Pharmaceuticals (SUPN)

Executed Sep 5 2025, disclosed Sep 8 2025, 3 days later.

Value, as filed

$2.6M

55,578 sh × $46.01

Executed

Sep 5 2025

the trade date, as filed

Disclosed

Sep 8 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JK Jack A. Khattar President, CEO profile →

Jack A. Khattar (President, CEO) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in SUPN. The largest single filing was $3.0M of SUPN (58,371 sh × $50.55, as filed), executed Oct 9 2025.

The name

SUPN SUPN SUPN · 38 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jack A. Khattar in SUPN

SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $1.8M
34,880 sh across 2 lots
Exec Mar 13
Filed Mar 16 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $3.0M
58,371 sh × $50.55
Exec Oct 9 2025
Filed Oct 10 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $1.9M
40,173 sh × $48.07
Exec Oct 1 2025
Filed Oct 2 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $414K
8,588 sh × $48.25
Exec Sep 30 2025
Filed Oct 1 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $491K
10,235 sh × $48.02
Exec Sep 29 2025
Filed Sep 30 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $1.4M
29,513 sh × $47.23
Exec Sep 23 2025
Filed Sep 24 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $780K
16,587 sh × $47.02
Exec Sep 22 2025
Filed Sep 23 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $293K
6,322 sh × $46.29
Exec Sep 8 2025
Filed Sep 9 2025 · 5:30 PM ET